ORAL CEPHALOSPORINS - NEWER AGENTS AND THEIR PLACE IN THERAPY

Cefprozil, cefpodoxime and loracarbef are three new oral cephalosporin s available for the treatment of common community-acquired infections. They share with other cephalosporins a low incidence of side effects and offer the convenience of twice-dally dosing. These agents can be c onsidered effective, although expensive, alternatives to traditional a ntibiotics in the treatment of skin, respiratory tract and urinary tra ct infections. Oral cefpodoxime offers an alternative to intramuscular antibiotics in the treatment of uncomplicated gonorrhea.